Symbols / RIGL Stock $27.36 -0.62% Rigel Pharmaceuticals, Inc.
RIGL (Stock) Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Market Cap | 549.41M | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | 1.53 | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | $27.53 | Price | $27.36 | Change | -0.62% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - PR Newswire ue, 03 Mar 2026 08
- RIGL (Rigel Pharmaceuticals Inc.) climbs two percent after Q4 2025 results, even as EPS falls short of analyst forecasts. - Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 20
- Eli Lilly ends Rigel (RIGL) RIPK1 licensing deal, no future milestones - Stock Titan ue, 21 Apr 2026 20
- FOLD vs. RIGL: Which Rare Disease Biotech Stock Has Better Upside? - Yahoo Finance Wed, 28 Jan 2026 08
- Rigel Pharmaceuticals, Inc. Common Stock (RIGL) Stock Price Today & Analysis - Gotrade ue, 13 Jan 2026 02
- Rigel Pharma stock slides on 2026 outlook (RIGL:NASDAQ) - Seeking Alpha Wed, 04 Mar 2026 08
- Rigel Regains Rights as Eli Lilly Ends Collaboration - TipRanks ue, 21 Apr 2026 21
- $RIGL stock is down 11% today. Here's what we see in our data. - Quiver Quantitative Wed, 04 Mar 2026 08
- RIGL Stock Rises 59% in a Year: Time to Buy, Hold or Sell? - Zacks Investment Research Mon, 16 Feb 2026 08
- Eli Lilly Ends Collaboration with Rigel Pharmaceuticals (LLY) - GuruFocus Wed, 22 Apr 2026 00
- Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR Newswire ue, 07 Apr 2026 07
- How The Rigel Pharmaceuticals (RIGL) Story Is Shifting With New Targets And Pipeline Progress - Yahoo Finance ue, 03 Mar 2026 08
- Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (Rating Upgrade) - Seeking Alpha hu, 09 Apr 2026 07
- Six new Rigel employees get stock awards that vest over 4 years - Stock Titan ue, 07 Apr 2026 07
- Why Analysts Say The Rigel Pharmaceuticals (RIGL) Story Is Shifting After Q3 And 2025 Guidance - Yahoo Finance Mon, 05 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
294.28
+64.15%
|
179.28
+53.38%
|
116.88
-2.79%
|
120.24
|
| Operating Revenue |
|
372.26
+52.38%
|
244.30
+53.03%
|
159.65
+5.00%
|
152.05
|
| Cost Of Revenue |
|
19.62
+5.22%
|
18.65
+162.26%
|
7.11
+306.52%
|
1.75
|
| Reconciled Cost Of Revenue |
|
19.62
+5.22%
|
18.65
+162.26%
|
7.11
+306.52%
|
1.75
|
| Gross Profit |
|
274.66
+70.99%
|
160.63
+46.33%
|
109.77
-7.36%
|
118.49
|
| Operating Expense |
|
149.19
+9.35%
|
136.44
+4.74%
|
130.26
-24.58%
|
172.72
|
| Research And Development |
|
33.30
+42.41%
|
23.38
-4.66%
|
24.52
-59.31%
|
60.27
|
| Selling General And Administration |
|
115.90
+2.51%
|
113.06
+6.92%
|
105.74
-5.97%
|
112.45
|
| Total Expenses |
|
168.82
+8.85%
|
155.09
+12.89%
|
137.37
-21.26%
|
174.47
|
| Operating Income |
|
125.47
+418.63%
|
24.19
+218.06%
|
-20.49
+62.21%
|
-54.23
|
| Total Operating Income As Reported |
|
125.47
+418.63%
|
24.19
+218.06%
|
-20.49
+63.11%
|
-55.55
|
| EBITDA |
|
131.56
+361.43%
|
28.51
+267.91%
|
-16.98
+68.48%
|
-53.87
|
| Normalized EBITDA |
|
131.56
+361.43%
|
28.51
+267.91%
|
-16.98
+67.68%
|
-52.55
|
| Reconciled Depreciation |
|
2.42
+8.39%
|
2.23
+79.97%
|
1.24
+24.05%
|
1.00
|
| EBIT |
|
129.15
+391.35%
|
26.28
+244.27%
|
-18.22
+66.79%
|
-54.87
|
| Total Unusual Items |
|
—
|
0.00
|
0.00
+100.00%
|
-1.32
|
| Total Unusual Items Excluding Goodwill |
|
—
|
0.00
|
0.00
+100.00%
|
-1.32
|
| Special Income Charges |
|
—
|
0.00
|
0.00
+100.00%
|
-1.32
|
| Restructuring And Mergern Acquisition |
|
—
|
0.00
|
0.00
-100.00%
|
1.32
|
| Net Income |
|
367.02
+1999.08%
|
17.48
+169.69%
|
-25.09
+57.16%
|
-58.57
|
| Pretax Income |
|
121.83
+563.33%
|
18.37
+173.20%
|
-25.09
+57.16%
|
-58.57
|
| Net Non Operating Interest Income Expense |
|
-3.64
+37.54%
|
-5.83
-26.65%
|
-4.60
-52.17%
|
-3.02
|
| Interest Expense Non Operating |
|
7.32
-7.55%
|
7.92
+15.22%
|
6.87
+85.38%
|
3.71
|
| Net Interest Income |
|
-3.64
+37.54%
|
-5.83
-26.65%
|
-4.60
-52.17%
|
-3.02
|
| Interest Expense |
|
7.32
-7.55%
|
7.92
+15.22%
|
6.87
+85.38%
|
3.71
|
| Interest Income Non Operating |
|
3.68
+75.96%
|
2.09
-7.92%
|
2.27
+232.16%
|
0.68
|
| Interest Income |
|
3.68
+75.96%
|
2.09
-7.92%
|
2.27
+232.16%
|
0.68
|
| Other Income Expense |
|
—
|
—
|
—
|
-1.32
|
| Tax Provision |
|
-245.20
-27931.67%
|
0.88
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
+337.50%
|
0.00
|
0.00
-100.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
+100.00%
|
-0.00
|
| Net Income Including Noncontrolling Interests |
|
367.02
+1999.08%
|
17.48
+169.69%
|
-25.09
+57.16%
|
-58.57
|
| Net Income From Continuing Operation Net Minority Interest |
|
367.02
+1999.08%
|
17.48
+169.69%
|
-25.09
+57.16%
|
-58.57
|
| Net Income From Continuing And Discontinued Operation |
|
367.02
+1999.08%
|
17.48
+169.69%
|
-25.09
+57.16%
|
-58.57
|
| Net Income Continuous Operations |
|
367.02
+1999.08%
|
17.48
+169.69%
|
-25.09
+57.16%
|
-58.57
|
| Normalized Income |
|
367.02
+1999.08%
|
17.48
+169.69%
|
-25.09
+56.18%
|
-57.25
|
| Net Income Common Stockholders |
|
367.02
+1999.08%
|
17.48
+169.69%
|
-25.09
+57.16%
|
-58.57
|
| Diluted EPS |
|
19.48
+1867.68%
|
0.99
+168.75%
|
-1.44
+57.65%
|
-3.40
|
| Basic EPS |
|
20.40
+1960.61%
|
0.99
+168.75%
|
-1.44
+57.65%
|
-3.40
|
| Basic Average Shares |
|
17.99
+2.32%
|
17.58
+1.02%
|
17.40
+0.93%
|
17.24
|
| Diluted Average Shares |
|
18.84
+6.52%
|
17.69
+1.64%
|
17.40
+0.93%
|
17.24
|
| Diluted NI Availto Com Stockholders |
|
367.02
+1999.08%
|
17.48
+169.69%
|
-25.09
+57.16%
|
-58.57
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
513.59
+213.21%
|
163.98
+39.88%
|
117.22
-12.70%
|
134.28
|
| Current Assets |
|
240.17
+77.77%
|
135.10
+36.10%
|
99.27
-14.35%
|
115.90
|
| Cash Cash Equivalents And Short Term Investments |
|
154.96
+100.40%
|
77.32
+35.81%
|
56.93
-2.19%
|
58.21
|
| Cash And Cash Equivalents |
|
40.58
-28.49%
|
56.75
+73.08%
|
32.79
+34.04%
|
24.46
|
| Other Short Term Investments |
|
114.38
+455.89%
|
20.57
-14.79%
|
24.15
-28.45%
|
33.75
|
| Receivables |
|
51.76
+24.39%
|
41.62
+36.22%
|
30.55
-24.23%
|
40.32
|
| Accounts Receivable |
|
51.76
+24.39%
|
41.62
+36.22%
|
30.55
-24.23%
|
40.32
|
| Gross Accounts Receivable |
|
52.10
+24.46%
|
41.86
+36.22%
|
30.73
|
—
|
| Allowance For Doubtful Accounts Receivable |
|
-0.34
-37.40%
|
-0.25
-36.67%
|
-0.18
|
—
|
| Inventory |
|
11.51
+91.70%
|
6.00
+8.69%
|
5.52
-39.44%
|
9.12
|
| Raw Materials |
|
—
|
—
|
—
|
4.55
|
| Work In Process |
|
—
|
—
|
—
|
2.66
|
| Finished Goods |
|
—
|
—
|
—
|
1.90
|
| Prepaid Assets |
|
16.73
+196.61%
|
5.64
|
—
|
—
|
| Other Current Assets |
|
5.21
+15.12%
|
4.52
-27.76%
|
6.26
-24.19%
|
8.26
|
| Total Non Current Assets |
|
273.43
+847.00%
|
28.87
+60.77%
|
17.96
-2.27%
|
18.38
|
| Net PPE |
|
0.92
+273.98%
|
0.25
-76.02%
|
1.03
-63.19%
|
2.79
|
| Gross PPE |
|
0.92
+273.98%
|
0.25
-90.99%
|
2.73
-79.92%
|
13.59
|
| Accumulated Depreciation |
|
—
|
-0.26
+84.68%
|
-1.70
+84.23%
|
-10.81
|
| Properties |
|
—
|
—
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
—
|
0.15
-57.85%
|
0.36
-82.28%
|
2.05
|
| Construction In Progress |
|
—
|
—
|
—
|
0.07
|
| Other Properties |
|
0.92
+273.98%
|
0.25
-89.61%
|
2.37
-74.92%
|
9.44
|
| Leases |
|
—
|
—
|
0.00
-100.00%
|
2.11
|
| Goodwill And Other Intangible Assets |
|
24.75
-8.68%
|
27.10
+95.27%
|
13.88
-7.16%
|
14.95
|
| Non Current Deferred Assets |
|
245.85
|
0.00
|
—
|
—
|
| Non Current Deferred Taxes Assets |
|
245.85
|
0.00
|
—
|
—
|
| Other Non Current Assets |
|
1.91
+24.95%
|
1.53
-50.02%
|
3.06
+377.34%
|
0.64
|
| Total Liabilities Net Minority Interest |
|
122.11
-24.01%
|
160.69
+10.16%
|
145.87
-1.37%
|
147.90
|
| Current Liabilities |
|
99.24
+56.77%
|
63.30
+18.83%
|
53.27
-18.32%
|
65.21
|
| Payables And Accrued Expenses |
|
22.83
+28.18%
|
17.81
+11.38%
|
15.99
-56.43%
|
36.70
|
| Payables |
|
7.19
+115.36%
|
3.34
-53.25%
|
7.14
-68.27%
|
22.51
|
| Accounts Payable |
|
7.19
+115.36%
|
3.34
-53.25%
|
7.14
-68.27%
|
22.51
|
| Current Accrued Expenses |
|
15.63
+8.06%
|
14.47
+63.55%
|
8.85
-37.67%
|
14.19
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
11.91
+17.51%
|
10.14
+16.86%
|
8.68
-2.14%
|
8.87
|
| Current Debt And Capital Lease Obligation |
|
30.43
+302.62%
|
7.56
-4.60%
|
7.92
+599.12%
|
1.13
|
| Current Debt |
|
29.81
+309.96%
|
7.27
+0.59%
|
7.23
|
—
|
| Other Current Borrowings |
|
29.81
+309.96%
|
7.27
+0.59%
|
7.23
|
—
|
| Current Capital Lease Obligation |
|
0.61
+115.44%
|
0.28
-58.82%
|
0.69
-38.92%
|
1.13
|
| Current Deferred Liabilities |
|
29.07
+4.59%
|
27.80
+63.13%
|
17.04
+26.08%
|
13.51
|
| Current Deferred Revenue |
|
29.07
+4.59%
|
27.80
+63.13%
|
17.04
+26.08%
|
13.51
|
| Other Current Liabilities |
|
5.00
|
—
|
3.64
-27.12%
|
5.00
|
| Total Non Current Liabilities Net Minority Interest |
|
22.88
-76.51%
|
97.39
+5.17%
|
92.60
+12.00%
|
82.68
|
| Long Term Debt And Capital Lease Obligation |
|
22.88
-56.35%
|
52.41
-0.47%
|
52.66
+30.28%
|
40.42
|
| Long Term Debt |
|
22.48
-57.10%
|
52.41
+0.07%
|
52.37
+32.76%
|
39.45
|
| Long Term Capital Lease Obligation |
|
0.40
|
0.00
-100.00%
|
0.28
-70.68%
|
0.97
|
| Other Non Current Liabilities |
|
—
|
44.98
+12.61%
|
39.94
-5.49%
|
42.26
|
| Stockholders Equity |
|
391.48
+11806.33%
|
3.29
+111.48%
|
-28.64
-110.37%
|
-13.62
|
| Common Stock Equity |
|
391.48
+11806.33%
|
3.29
+111.48%
|
-28.64
-110.37%
|
-13.62
|
| Capital Stock |
|
0.02
+0.00%
|
0.02
+5.88%
|
0.02
-90.23%
|
0.17
|
| Common Stock |
|
0.02
+0.00%
|
0.02
+5.88%
|
0.02
-90.23%
|
0.17
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
18.31
+3.39%
|
17.71
+1.30%
|
17.48
+0.82%
|
17.34
|
| Ordinary Shares Number |
|
18.31
+3.39%
|
17.71
+1.30%
|
17.48
+0.82%
|
17.34
|
| Additional Paid In Capital |
|
1,414.32
+1.51%
|
1,393.33
+1.05%
|
1,378.88
+0.73%
|
1,368.82
|
| Retained Earnings |
|
-1,023.04
+26.40%
|
-1,390.07
+1.24%
|
-1,407.55
-1.81%
|
-1,382.46
|
| Gains Losses Not Affecting Retained Earnings |
|
0.18
+1710.00%
|
0.01
+25.00%
|
0.01
+105.23%
|
-0.15
|
| Other Equity Adjustments |
|
0.18
+1710.00%
|
0.01
+25.00%
|
0.01
+105.23%
|
-0.15
|
| Total Equity Gross Minority Interest |
|
391.48
+11806.33%
|
3.29
+111.48%
|
-28.64
-110.37%
|
-13.62
|
| Total Capitalization |
|
413.96
+643.25%
|
55.70
+134.72%
|
23.73
-8.14%
|
25.83
|
| Working Capital |
|
140.93
+96.27%
|
71.80
+56.10%
|
46.00
-9.26%
|
50.69
|
| Invested Capital |
|
443.77
+604.76%
|
62.97
+103.40%
|
30.96
+19.84%
|
25.83
|
| Total Debt |
|
53.30
-11.11%
|
59.97
-1.01%
|
60.58
+45.79%
|
41.55
|
| Net Debt |
|
11.71
+299.25%
|
2.93
-89.06%
|
26.82
+78.90%
|
14.99
|
| Capital Lease Obligations |
|
1.01
+254.04%
|
0.28
-70.83%
|
0.98
-53.59%
|
2.10
|
| Net Tangible Assets |
|
366.73
+1640.11%
|
-23.81
+44.00%
|
-42.52
-48.86%
|
-28.57
|
| Tangible Book Value |
|
366.73
+1640.11%
|
-23.81
+44.00%
|
-42.52
-48.86%
|
-28.57
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
75.66
+140.40%
|
31.47
+647.99%
|
-5.74
+92.21%
|
-73.76
|
| Cash Flow From Continuing Operating Activities |
|
75.66
+140.40%
|
31.47
+647.99%
|
-5.74
+92.21%
|
-73.76
|
| Net Income From Continuing Operations |
|
367.02
+1999.08%
|
17.48
+169.69%
|
-25.09
+57.16%
|
-58.57
|
| Depreciation Amortization Depletion |
|
2.42
+8.39%
|
2.23
+79.97%
|
1.24
+24.05%
|
1.00
|
| Depreciation And Amortization |
|
2.42
+8.39%
|
2.23
+79.97%
|
1.24
+24.05%
|
1.00
|
| Other Non Cash Items |
|
-39.98
|
—
|
—
|
0.68
|
| Stock Based Compensation |
|
12.71
+2.57%
|
12.39
+40.73%
|
8.81
-28.90%
|
12.38
|
| Deferred Tax |
|
-245.85
|
0.00
|
0.00
|
—
|
| Deferred Income Tax |
|
-245.85
|
0.00
|
0.00
|
—
|
| Operating Gains Losses |
|
—
|
-0.08
-129.70%
|
0.27
+292.75%
|
-0.14
|
| Gain Loss On Sale Of PPE |
|
0.00
+100.00%
|
-0.08
-129.70%
|
0.27
+292.75%
|
-0.14
|
| Change In Working Capital |
|
-19.51
-12852.94%
|
0.15
-98.39%
|
9.52
+132.76%
|
-29.05
|
| Change In Receivables |
|
-10.15
+8.29%
|
-11.06
-213.25%
|
9.77
+139.32%
|
-24.85
|
| Changes In Account Receivables |
|
-10.15
+8.29%
|
-11.06
-213.25%
|
9.77
+139.32%
|
-24.85
|
| Change In Inventory |
|
-5.63
-837.57%
|
0.76
-34.81%
|
1.17
+149.31%
|
-2.38
|
| Change In Prepaid Assets |
|
-11.85
-244.42%
|
-3.44
-267.48%
|
2.05
+500.39%
|
-0.51
|
| Change In Payables And Accrued Expense |
|
5.30
+263.52%
|
-3.24
+28.90%
|
-4.56
-261.68%
|
2.82
|
| Change In Accrued Expense |
|
1.45
+159.11%
|
0.56
+113.35%
|
-4.20
-333.82%
|
-0.97
|
| Change In Payable |
|
3.85
+201.29%
|
-3.80
-939.07%
|
-0.37
-109.66%
|
3.79
|
| Change In Account Payable |
|
3.85
+201.29%
|
-3.80
-939.07%
|
-0.37
-109.66%
|
3.79
|
| Change In Other Working Capital |
|
3.05
-75.03%
|
12.22
+264.86%
|
3.35
+184.05%
|
1.18
|
| Change In Other Current Assets |
|
-0.67
-209.59%
|
0.61
-42.47%
|
1.07
-86.25%
|
7.77
|
| Change In Other Current Liabilities |
|
0.44
-89.80%
|
4.30
+228.99%
|
-3.34
+74.50%
|
-13.08
|
| Investing Cash Flow |
|
-92.36
-2336.44%
|
4.13
+196.11%
|
-4.30
-105.90%
|
72.78
|
| Cash Flow From Continuing Investing Activities |
|
-92.36
-2336.44%
|
4.13
+196.11%
|
-4.30
-105.90%
|
72.78
|
| Net PPE Purchase And Sale |
|
0.00
-100.00%
|
0.10
-62.16%
|
0.26
-71.00%
|
0.89
|
| Purchase Of PPE |
|
—
|
—
|
0.00
+100.00%
|
-0.45
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.10
-62.16%
|
0.26
-71.00%
|
0.89
|
| Capital Expenditure |
|
—
|
-0.40
+97.36%
|
-15.00
-3233.33%
|
-0.45
|
| Capital Expenditure Reported |
|
0.00
+100.00%
|
-0.04
|
0.00
+100.00%
|
-0.45
|
| Net Investment Purchase And Sale |
|
-92.36
-2185.93%
|
4.43
-57.60%
|
10.44
-85.56%
|
72.33
|
| Purchase Of Investment |
|
-153.49
-335.17%
|
-35.27
-13.03%
|
-31.21
-8.00%
|
-28.89
|
| Sale Of Investment |
|
61.13
+53.98%
|
39.70
-4.68%
|
41.65
-58.86%
|
101.23
|
| Net Intangibles Purchase And Sale |
|
0.00
+100.00%
|
-0.36
+97.60%
|
-15.00
|
0.00
|
| Purchase Of Intangibles |
|
0.00
+100.00%
|
-0.36
+97.60%
|
-15.00
|
0.00
|
| Financing Cash Flow |
|
0.60
+105.16%
|
-11.64
-163.38%
|
18.37
+180.41%
|
6.55
|
| Cash Flow From Continuing Financing Activities |
|
0.60
+105.16%
|
-11.64
-163.38%
|
18.37
+180.41%
|
6.55
|
| Net Issuance Payments Of Debt |
|
-7.50
|
0.00
-100.00%
|
19.95
+2.09%
|
19.54
|
| Issuance Of Debt |
|
0.00
|
0.00
-100.00%
|
19.95
+2.09%
|
19.54
|
| Repayment Of Debt |
|
-7.50
|
0.00
|
0.00
|
—
|
| Long Term Debt Issuance |
|
0.00
|
0.00
-100.00%
|
19.95
+2.09%
|
19.54
|
| Long Term Debt Payments |
|
-7.50
|
0.00
|
0.00
|
—
|
| Net Long Term Debt Issuance |
|
-7.50
|
0.00
-100.00%
|
19.95
+2.09%
|
19.54
|
| Net Common Stock Issuance |
|
0.00
+100.00%
|
-10.00
|
0.00
|
0.00
|
| Common Stock Payments |
|
0.00
+100.00%
|
-10.00
|
0.00
|
0.00
|
| Repurchase Of Capital Stock |
|
0.00
+100.00%
|
-10.00
|
0.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
8.10
+312.47%
|
1.96
+87.23%
|
1.05
-50.61%
|
2.12
|
| Net Other Financing Charges |
|
—
|
-3.60
-36.97%
|
-2.63
+82.59%
|
-15.12
|
| Changes In Cash |
|
-16.11
-167.23%
|
23.96
+187.74%
|
8.33
+49.52%
|
5.57
|
| Beginning Cash Position |
|
56.75
+73.08%
|
32.79
+34.04%
|
24.46
+29.48%
|
18.89
|
| End Cash Position |
|
40.64
-28.39%
|
56.75
+73.08%
|
32.79
+34.04%
|
24.46
|
| Free Cash Flow |
|
75.66
+143.46%
|
31.07
+249.81%
|
-20.74
+72.05%
|
-74.21
|
| Interest Paid Supplemental Data |
|
6.57
-6.62%
|
7.04
+20.37%
|
5.85
+134.39%
|
2.50
|
| Income Tax Paid Supplemental Data |
|
1.06
+221.15%
|
0.33
+308.64%
|
0.08
|
0.00
|
| Amortization Of Securities |
|
-1.15
-62.20%
|
-0.71
-48.02%
|
-0.48
-660.32%
|
-0.06
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-21 View
- 8-K2026-03-03 View
- 10-K2026-03-03 View
- 42026-02-24 View
- 42026-02-19 View
- 42026-02-19 View
- 42026-02-19 View
- 42026-02-19 View
- 42026-02-19 View
- 42026-02-12 View
- 42026-02-12 View
- 42026-02-12 View
- 42026-02-12 View
- 42026-02-12 View
- 42026-02-04 View
- 42026-02-04 View
- 42026-02-04 View
- 42026-02-04 View
- 42026-02-03 View
- 8-K2026-02-03 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|